ライフサイエンスコーパス: social phobia

1 egorical diagnoses (e.g., panic disorder and social phobia).

2 sorder, premenstrual dysphoric disorder, and social phobia.

3 he effects of SSRI treatment for generalized social phobia.

4 ly has an impact on risk for agoraphobia and social phobia.

5 specifically referred for an evaluation for social phobia.

6 about specific functional impairment due to social phobia.

7 eek, open trial of nine patients with DSM-IV social phobia.

8 pharmacologic management of serious forms of social phobia.

9 bsessive-compulsive disorder, depression, or social phobia.

10 erapy may have efficacy for the treatment of social phobia.

11 oximated those of established treatments for social phobia.

12 tive treatment for patients with generalized social phobia.

13 ine oxidase inhibitor phenelzine sulfate for social phobia.

14 er in relatives of probands with generalized social phobia.

15 or depression, alcohol abuse/dependence, and social phobia.

16 ng the families of probands with generalized social phobia.

17 relatives of 24 comparison subjects without social phobia.

18 earlier finding of a familial liability for social phobia.

19 among relatives of probands with generalized social phobia.

20 for simple phobia, and 13.3% (and 4.5%) for social phobia.

21 ttern of striatal activation may manifest in social phobia.

22 ildhood behavioral inhibition and adolescent social phobia.

23 rage longitudinal fMRI studies of adolescent social phobia.

24 face processing also manifest in adolescent social phobia.

25 fferentially affects response in generalized social phobia.

26 social stimuli more generally in generalized social phobia.

27 disorder, generalized anxiety disorder, and social phobia.

28 chiatric disorders, including depression and social phobia.

29 to 0.77); GAD, 0.87 (95% CI, 0.53 to 1.00); social phobia, 0.70 (95% CI, 0.31 to 1.00); and panic di

30 (31%), agoraphobia or panic disorder (22%), social phobia (17%), and specific phobia (15%).

31 ed in 58 medication-free adolescents-14 with social phobia, 18 with generalized anxiety disorder but

32 ared in 39 medication-free participants with social phobia (25 adults and 14 adolescents) and 39 heal

33 re most marked among patients diagnosed with social phobia (29% to 8%), dysthymic disorder (65% to 30

34 imple (3.3% vs. 11.5%, Z=-3.13, p<0.001) and social phobias (3.9% vs. 9.7%, Z=2.38, p<0.05) were sign

35 isorder (9.3%), specific phobias (8.8%), and social phobia (6.6%).

36 Among those with DSM-IV social phobia (7.2%), classification based on number (no

37 6.7% for panic disorder, 12.6% vs. 25.3% for social phobia, 9.1% vs. 25.9% for alcohol abuse or depen

38 is also associated with risk for adolescent social phobia, a similar pattern of striatal activation

39 ic and environmental risk for three phobias (social phobia, agoraphobia, and animal phobia) in twins

40 confirm earlier findings of a higher rate of social phobia among relatives of probands with generaliz

41 Sixteen patients with generalized social phobia and 16 healthy comparison subjects group-m

42 ee relatives of 23 patients with generalized social phobia and 74 first-degree relatives of 24 compar

43 d these indices for persons with and without social phobia and adjusted where indicated for the effec

44 All of the genetic risk factors for social phobia and agoraphobia were shared with those tha

45 e and negative between extraversion and both social phobia and agoraphobia, and that between extraver

46 gh and positive between neuroticism and both social phobia and agoraphobia, and that between neurotic

47 ccount entirely for the genetic liability to social phobia and agoraphobia, but not animal phobia.

48 a greater-than-expected association between social phobia and alcohol use disorders.

49 Relative risks for generalized social phobia and avoidant personality disorder were mar

50 with social phobia, depression, or comorbid social phobia and depression.

51 ial phobia, depressive disorder, or comorbid social phobia and depressive disorder and 44 healthy com

52 among relatives of probands with generalized social phobia and extend these findings by specifically

53 esponse to facial expressions in generalized social phobia and generalized anxiety disorder.

54 circuitry dysfunctions differ in generalized social phobia and generalized anxiety disorder.

55 receptor binding potential in patients with social phobia and healthy comparison subjects.

56 vely assessed among individuals with DSM-III social phobia and individuals with subclinical social ph

57 differences in favor of CBT for measures of social phobia and interpersonal problems, but not for de

58 in 10 unmedicated subjects with generalized social phobia and no significant lifetime psychiatric co

59 In contrast, relative risks for discrete social phobia and nongeneralized social phobia were not

60 d in patients with anxiety disorders such as social phobia and posttraumatic stress disorder (PTSD).

61 ove our understanding of the relationship of social phobia and risk for alcohol conditions, which may

62 ession was used to assess the association of social phobia and subclinical social phobia with inciden

63 in individuals, between either depression or social phobia and the broad autism phenotype.

64 ression and anxiety-related disorders, e.g., social phobias and post-traumatic stress disorder.

65 18 with generalized anxiety disorder but not social phobia, and 26 with no psychiatric disorder-match

66 ion in healthy adolescents, adolescents with social phobia, and adolescents with generalized anxiety

67 inson's disease therapy, ataxia, depression, social phobia, and behaviour disturbances following brai

68 ts, psychiatric comorbidity (panic disorder, social phobia, and drug dependence), disability and rest

69 ity disorder, posttraumatic stress disorder, social phobia, and mania showed dav between 0.68 and 0.9

70 iety disorders, panic disorder, agoraphobia, social phobia, and obsessive-compulsive disorder.

71 ic disorders, such as autism, schizophrenia, social phobia, and others.

72 sorders, generalized anxiety disorder (GAD), social phobia, and panic disorder were obtained from nat

73 ty of life for patients with panic disorder, social phobia, and posttraumatic stress disorder.

74 mined hemispheric asymmetries of function in social phobia, and the influence of comorbidity with dep

75 ersonal relationships; these include autism, social phobia, and the personality disorders.

76 isorder independently predicted new onset of social phobia, and the two interacted to predict new ons

77 etween OCD and GAD, intermediate for OCD and social phobia, and weakest between OCD and panic disorde

78 anic disorder, generalized anxiety disorder, social phobia, and/or posttraumatic stress disorder (wit

79 xiety disorder, panic disorder, agoraphobia, social phobia, animal phobia, and situational phobia) we

80 xiety disorder, panic disorder, agoraphobia, social phobia, animal phobia, situational phobia, and ne

81 e, panic, or posttraumatic stress disorders; social phobia; anxious or melancholic features; or more

82 Most comorbid simple and social phobias are temporally primary, while most comorb

83 Several anxiety disorders, including social phobia, are genetically influenced.

84 to what extent indices were attributable to social phobia as opposed to comorbid major depression.

85 e 33 individuals with a DSM-III diagnosis of social phobia at baseline, only one developed heavy drin

86 e of specificity in the course of simple and social phobia but less specificity in the course of othe

87 e course of generalized anxiety disorder and social phobia but not panic disorder, suggesting that Pe

88 d be higher rates of the generalized type of social phobia--but not the nongeneralized (or "discrete"

89 Social phobia can be a serious, disabling anxiety disord

90 rbid with other DSM-III-R disorders than was social phobia characterized by other social fears.

91 pidemiologic data on the distinction between social phobia characterized by pure speaking fears and t

92 However, the social phobia characterized by pure speaking fears was l

93 alized cognitive processing in patients with social phobia, depression, or comorbid social phobia and

94 A total of 125 unmedicated patients with social phobia, depressive disorder, or comorbid social p

95 compulsive disorder, psychosis, agoraphobia, social phobia, drug abuse/dependence, antisocial persona

96 The neural correlates of adult social phobia during face processing also manifest in ad

97 rmine whether the neural correlates of adult social phobia during face processing also manifest in ad

98 stic Interview-Version 2.1 module for DSM-IV social phobia, enhanced with 6 additional (for a total o

99 hobia, predominantly concurrent (same year); social phobia, equal proportions primary and concurrent;

100 nic disorder (PD), and phobias (agoraphobia, social phobia, etc.).

101 One-third of the people with lifetime social phobia exclusively reported speaking fears, while

102 Evidence for linkage to social phobia for chromosome 16 markers was identified.

103 Six mental disorders (social phobia, generalised anxiety disorder, major depre

104 anic disorder, agoraphobia, specific phobia, social phobia, generalized anxiety disorder, posttraumat

105 cluded 57 probands with an anxiety disorder (social phobia, generalized anxiety disorder, separation

106 Within the social phobia group, there was a nonsignificant correlat

107 sponse relative to the healthy comparison or social phobia group.

108 Generalized social phobia (GSP) and generalized anxiety disorder (GA

109 Generalized social phobia (GSP) is characterized by fear of social i

110 Generalized social phobia (GSP) is characterized by fear/avoidance o

111 Generalized social phobia (gSP), also known as generalized social an

112 ng of social anxiety disorder (also known as social phobia) has moved from rudimentary awareness that

113 ess, depression, generalized anxiety, panic, social phobia) have remained the strongest predictors of

114 consequences, comorbid conduct disorder and social phobia, higher interpersonal dependency and lower

115 Patients with generalized social phobia, however, showed significantly increased r

116 nge of functional impairment attributable to social phobia in a community sample, and (2) to verify t

117 While social phobia in adolescence predicts the illness in adu

118 as directly compared the neural responses in social phobia in adults and adolescents.

119 Social phobia in clinical studies is vividly associated

120 portrayal of the impairment associated with social phobia in community samples.

121 and difficulty experienced by patients with social phobia in social situations.

122 Rather, social phobia in the community seems to exist on a conti

123 aroxetine treatment at weeks 1 and 2 for the Social Phobia Inventory (P < .05 for all).

124 12 on the Liebowitz Social Anxiety Scale and Social Phobia Inventory and at week 2 and weeks 6 throug

125 n the Liebowitz Social Anxiety Scale and the Social Phobia Inventory scores were compared across the

126 al Global Impression-Severity of Illness and Social Phobia Inventory scores.

127 mpression-Severity of Illness scale, and the Social Phobia Inventory, and at weeks 4 through 12 for r

128 , Panic Disorder Severity-Self-report Scale, Social Phobia Inventory, and PTSD Checklist-Civilian Ver

129 symptoms: the Brief Social Phobia Scale, the Social Phobia Inventory, and the Liebowitz Social Anxiet

130 Generalized social phobia involves fear/avoidance, specifically of s

131 cial phobia and individuals with subclinical social phobia (irrational fear of social situations with

132 Social phobia is a common, sometimes disabling, fear of

133 The results support the hypothesis that social phobia is associated with dysfunction of left hem

134 Social phobia is associated with substantial impairment

135 Generalized social phobia is common, persistent, and disabling and i

136 Impairment in social phobia is substantial, even in the absence of com

137 ocial anxiety disorder (SAD) (also known as "social phobia") is frequently comorbid with major depres

138 d risk of current panic disorder, dysthymia, social phobia, major depression, and generalized anxiety

139 der, was associated with increased risks for social phobia, major depression, disruptive behavior dis

140 iety disorder, generalized anxiety disorder, social phobia, major depression, dysthymic disorder, and

141 Generalized social phobia may be associated with low binding of [(12

142 Neural correlates that are observed in adult social phobia may represent the persistence of profiles

143 generalized anxiety, separation anxiety, and social phobia (n = 22) compared with matched controls (n

144 Treatment-seeking individuals with social phobia (N = 40) were asked to give two impromptu

145 -compulsive disorder (OCD) (N=277 [41%]) and social phobia (N=134 [20%]).

146 , generalized anxiety disorder, agoraphobia, social phobia, obsessive-compulsive disorder, anorexia,

147 Social anxiety disorder (social phobia or avoidant disorder) was significantly mo

148 nd to placebo than patients with generalized social phobia or panic disorder.

149 neralized anxiety disorder, agoraphobia, and social phobia or panic) diagnosed according to the Natio

150 ce was 2.30, relative to respondents without social phobia or subclinical social fears.

151 c disorder (OR, 1.3; 95% CI, 1.06-1.59), and social phobia (OR, 1.3; 95% CI, 1.09-1.64).

152 th DSM-IV anxiety disorders (panic disorder, social phobia, or obsessive-compulsive disorder) and to

153 patients with obsessive-compulsive disorder, social phobia, or panic disorder who received placebo in

154 patients with generalized anxiety disorder, social phobia, or panic disorder.

155 ety disorders (generalized anxiety disorder, social phobia, panic disorder, and posttraumatic stress

156 these regions, both the adolescent and adult social phobia patients showed significantly increased BO

157 eptualized) in patients with panic disorder, social phobia, posttraumatic stress disorder, generalize

158 60]), general anxiety (PR 1.49 [1.40-1.59]), social phobia (PR 1.62 [1.48-1.78]), self-harm (PR 1.86

159 two factorial design in which one factor was social phobia (present versus absent) and the second fac

160 orted on symptoms of generalized anxiety and social phobia prior to participating in a neuroimaging v

161 , fluvoxamine was superior to placebo on all social phobia rating scales at week 8 and beyond.

162 creasing magnitudes characterizes adolescent social phobia, relative to activation in this region in

163 isorder remission, a 39% lower likelihood of social phobia remission, and no difference in likelihood

164 nt PersD predicted a 41% lower likelihood of social phobia remission.

165 bilaterally, reflecting elevated generalized social phobia responses in these regions to all event ty

166 and physiological candidate for influencing social phobia risk.

167 On the Brief Social Phobia Scale, all active treatments were superior

168 scales for social phobia symptoms: the Brief Social Phobia Scale, the Social Phobia Inventory, and th

169 es of increasing magnitude, adolescents with social phobia showed increasingly heightened caudate and

170 The generalized type of social phobia (social anxiety disorder) is a severe and

171 efficacy of fluvoxamine for the treatment of social phobia (social anxiety disorder).

172 xiety disorder, separation anxiety disorder, social phobia, specific phobia, agoraphobia, and obsessi

173 xiety disorder, separation anxiety disorder, social phobia, specific phobia, agoraphobia, and obsessi

174 the participants reported the onset of OCD, social phobia, specific phobia, and generalized anxiety

175 or depression, generalized anxiety disorder, social phobia, specific phobia, post-traumatic stress di

176 ve disorder, post-traumatic stress disorder, social phobia, specific phobias and generalized anxiety

177 cortex in the pathophysiology of generalized social phobia, specifically through its involvement in d

178 raction fears is needed to determine whether social phobia subtypes can be refined and whether the su

179 The authors examined rates of three social phobia subtypes defined a priori--discrete, nonge

180 y sample, and (2) to verify the existence of social phobia subtypes in the community, and report on t

181 21); this association broadened to panic and social phobia symptoms in adolescence (r = 0.17-0.24 and

182 ly all clinician ratings and self-ratings of social phobia symptoms significantly improved.

183 ted as much or very much improved on overall social phobia symptoms.

184 over 40 min) and placebo (normal saline) on social phobia symptoms.

185 anges on three specialized rating scales for social phobia symptoms: the Brief Social Phobia Scale, t

186 egree relatives of probands with generalized social phobia than among first-degree relatives of compa

187 was significantly lower in the subjects with social phobia than in the comparison subjects.

188 igher rates of major depressive disorder and social phobia than the parents of the Down's syndrome pr

189 uals have high rates of major depression and social phobia that are not associated with the broad aut

190 84 individuals with a history of subclinical social phobia, the cumulative incidence rates of heavy d

191 tion, and psychiatric disorders ranging from social phobia to autism.

192 l expressions in adults and adolescents with social phobia to determine whether the neural correlates

193 gnificantly more likely than persons without social phobia to rate themselves as "low functioning" on

194 y disorder, generalized anxiety disorder, or social phobia to receive 14 sessions of cognitive behavi

195 drinking among respondents with subclinical social phobia was 2.41, and the estimated relative risk

196 Social phobia was assessed with a revised version of the

197 Social phobia was intermediate in that it was influenced

198 In addition, the severity of social phobia was significantly correlated with the enha

199 ibitors (SSRIs) in patients with generalized social phobia was tested.

200 Identifying loci for social phobia was the goal of this study.

201 nparametric (Zlr score) linkage analyses for social phobia were completed with Allegro and Genehunter

202 Persons with social phobia were impaired on a broad spectrum of measu

203 or discrete social phobia and nongeneralized social phobia were not significantly different between t

204 ers, Fourth Edition criteria for generalized social phobia were randomized (and 183 returned for at l

205 s meeting a primary diagnosis of generalized social phobia were recruited via advertisement.

206 , placebo-controlled trial, 92 patients with social phobia were treated with the selective serotonin

207 nd syllables, compared with subjects without social phobia, whereas no difference between groups was

208 bout the neural underpinnings of generalized social phobia, which is defined by a persistent heighten

209 Subjects were 14 patients with generalized social phobia who were less than "very much improved" on

210 association of social phobia and subclinical social phobia with incident alcohol abuse/dependence and

211 In the meantime, people who have social phobia with multiple fears, some of which are non

212 Patients with social phobia with or without a comorbid depressive diso

213 ched on age, IQ, and gender with generalized social phobia without generalized anxiety disorder (N=17

214 The patients with generalized social phobia without generalized anxiety disorder showe

215 eported anxiety in patients with generalized social phobia without generalized anxiety disorder.